LeanLife Health Inc.
LLP.CN · CNQ
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.23 | 0.54 | 0.07 | -0.18 |
| FCF Yield | 1.15% | -3.55% | -3.23% | -2.99% |
| EV / EBITDA | -8.07 | -17.54 | -17.70 | -21.47 |
| Quality | ||||
| ROIC | 101.30% | 206.29% | -488.47% | -300.36% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.09 | 0.61 | 0.55 | 0.22 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 114.08% | -2.50% | 11.89% | 25.27% |
| Safety | ||||
| Net Debt / EBITDA | -0.26 | -0.38 | -0.32 | 0.02 |
| Interest Coverage | -231.46 | -175.32 | -206.06 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -99,572.31 | -16,613.12 | 11,170.72 | -49,935.86 |